B10 cell regulation of health and disease

Immunological Reviews

Volumn 259, Issue 1, 2014, Pages 259-272

  Candando, Kathleen M ^a   Lykken, Jacquelyn M ^a   Tedder, Thomas F ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Autoimmunity; B cells; B10 cells; IL 10; Immunosuppression

Indexed keywords

CD19 ANTIGEN; CD24 ANTIGEN; CD40 ANTIGEN; CD40 LIGAND; CD5 ANTIGEN; IMMUNOGLOBULIN M; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 21 RECEPTOR; LEUKOSIALIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; PHORBOL 13 ACETATE 12 MYRISTATE; PROTEIN KINASE C ACTIVATOR; TUMOR NECROSIS FACTOR ALPHA;

ADOPTIVE TRANSFER; ALLERGIC DISEASE; ANTIBODY PRODUCTION; ARTHRITIS; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNITY; B LYMPHOCYTE; B LYMPHOCYTE ACTIVATION; B10 CELL; BACTERIAL LOAD; CELL DIFFERENTIATION; CELL FUNCTION; CELL INTERACTION; CELL MATURATION; CELL POPULATION; CELL PROLIFERATION; CELL SURFACE; CELLULAR DISTRIBUTION; CHRONIC LYMPHATIC LEUKEMIA; COLITIS; CYTOKINE PRODUCTION; CYTOKINE RELEASE; CYTOLOGY; GLOMERULONEPHRITIS; GRAFT REJECTION; HUMAN; IMMUNE RESPONSE; IN VITRO STUDY; INFECTION; INNATE IMMUNITY; MACROPHAGE; NEOPLASM; NONHUMAN; OLIGODENDROGLIA; PATHOGEN CLEARANCE; PATHOGENESIS; PERITONEAL CAVITY; PHENOTYPE; PRIORITY JOURNAL; PROTEINURIA; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE;

AUTOIMMUNITY; B CELLS; B10 CELLS; IL-10; IMMUNOSUPPRESSION;

ANIMALS; AUTOIMMUNE DISEASES; AUTOIMMUNITY; B-LYMPHOCYTE SUBSETS; B-LYMPHOCYTES, REGULATORY; HUMANS; IMMUNITY; IMMUNOMODULATION; INTERLEUKIN-10; MICE; PHENOTYPE;

EID: 84897942212     PISSN: 01052896     EISSN: 1600065X     Source Type: Journal    
DOI: 10.1111/imr.12176     Document Type: Article

References (63)

1. LeBien TW, Tedder TF. B-lymphocytes: how they develop and function. Blood 2008;112:1570-1579.
2. Katz SI, Parker D, Turk JL. B-cell suppression of delayed hypersensitivity reactions. Nature 1974;251:550-551.
3. Gorczynski RM. Immunity to murine sarcoma virus-inducted tumors. II. Suppression of T cell-mediated immunity by cells from progressor animals. J Immunol 1974;112:1826-1838.
4. Mizoguchi A, Mizoguchi E, Takedatsu H, Blumberg RS, Bhan AK. Chronic intestinal inflammatory condition generates IL-10-producing regulatory B cell subset characterized by CD1d upregulation. Immunity 2002;16:219-230.
5. Mizoguchi A, Bhan AK. A case for regulatory B cells. J Immunol 2006;176:705-710.
6. Fillatreau S, Sweenie CH, McGeachy MJ, Gray D, Anderton SM. B cells regulate autoimmunity by provision of IL-10. Nat Immunol 2002;3:944-950.
7. Bouaziz J-D, Yanaba K, Tedder TF. Regulatory B cells as inhibitors of immune responses and inflammation. Immunol Rev 2008;224:201-214.
8. Yanaba K, Bouaziz JD, Matsushita T, Magro CM, St. Clair EW, Tedder TF. B-lymphocyte contributions to human autoimmune disease. Immunol Rev 2008;223:284-299.
9. DiLillo DJ, Matsushita T, Tedder TF. B10 cells and regulatory B cells balance immune responses during inflammation, autoimmunity, and cancer. Ann N Y Acad Sci 2010;1183:38-57.
10. Matsushita T, Tedder TF. B lymphocyte depletion for the treatment of multiple sclerosis: now things really get interesting. Expert Rev Neutother 2009;9:309-312.
11. + T cell immunity. Nat Rev Immunol 2010;10:236-247.
12. Fillatreau S. Novel regulatory functions for Toll-like receptor-activated B cells during intracellular bacterial infection. Immunol Rev 2011;240:52-71.
13. Mauri C, Bosma A. Immune regulatory function of B cells. Annu Rev Immunol 2012;30:221-241.
14. Tedder TF, Matsushita T. Regulatory B cells that produce IL-10: a breath of fresh air in allergic airway disease. J Allergy Clin Immunol 2010;125:1125-1127.
15. DiLillo DJ, Horikawa M, Tedder TF. B-lymphocyte effector functions in health and disease. Immunol Res 2011;49:281-292.
16. Kalampokis I, Yoshizaki A, Tedder TF. IL-10-producing regulatory B cells (B10 cells) in autoimmune disease. Arthritis Res Ther 2013;15(Suppl 1):S1.
17. + phenotype controls T cell-dependent inflammatory responses. Immunity 2008;28:639-650.
18. Bouabe H. Cytokine reporter mice: The special case of IL-10. Scand J Immunol 2012;75:553-567.
19. Matsushita T, Tedder TF. Identifying regulatory B cells (B10 cells) that produce IL-10. Methods Mol Biol 2011;677:99-111.
20. Yanaba K, Bouaziz JD, Matsushita T, Tsubata T, Tedder TF. The development and function of regulatory B cells expressing IL-10 (B10 cells) requires antigen receptor diversity and TLR signals. J Immunol 2009;182:7459-7472.
21. Brummel R, Lenert P. Activation of marginal zone B cells from lupus mice with type A(D) CpG-oligodeoxynucleotides. J Immunol 2005;174:2429-2434.
22. Gray M, Miles K, Salter D, Gray D, Savill J. Apoptotic cells protect mice from autoimmune inflammation by the induction of regulatory B cells. Proc Natl Acad Sci USA 2007;104:14080-14085.
23. Poe JC, et al. Amplified B lymphocyte CD40 signaling drives regulatory B10 cell expansion in mice. PLoS ONE 2011;6:e22464.
24. + T cell numbers during colitis development in mice. J Immunol 2013;191:2780-2795.
25. Matsushita T, Horikawa M, Iwata Y, Tedder TF. Regulatory B cells (B10 cells) and regulatory T cells have independent roles in controlling EAE initiation and late-phase immunopathogenesis. J Immunol 2010;185:2240-2252.
26. Yoshizaki A, et al. Regulatory B cells control T cell autoimmunity through IL-21-dependent cognate interactions. Nature 2012;491:264-268.
27. Maseda D, et al. Regulatory B10 cells differentiate into antibody-secreting cells after transient IL-10 production in vivo. J Immunol 2012;188:1036-1048.
28. Saraiva M, O'Garra A. The regulation of IL-10 production by immune cells. Nat Rev Immunol 2010;10:170-181.
29. Horikawa M, et al. Reglatory B cell (B10 cell) expansion during Listeria infection governs innate and cellular immune responses in mice. J Immunol 2013;190:1158-1168.
30. DiLillo DJ, et al. Chronic lymphocytic leukemia and regulatory B cells share IL-10 competence and immunosuppressive function. Leukemia 2012;27:170-182.
31. Matsushita T, et al. Inhibitory role of CD19 in the progression of experimental autoimmune encephalomyelitis by regulating cytokine response. Am J Pathol 2006;168:812-821.
32. Watanabe R, et al. CD19 expression in B cells is important for suppression of contact hypersensitivity. Am J Pathol 2007;171:560-570.
33. DiLillo DJ, et al. B lymphocytes differentially influence acute and chronic allograft rejection in mice. J Immunol 2011;186:2643-2654.
34. Yanaba K, et al. Regulatory B cells suppress imiquimod-induced, psoriasis-like skin inflammation. J Leukoc Biol 2013;94:563-573.
35. Le Huu D, et al. Donor-derived regulatory B cells are important for suppression of murine sclerodermatous chronic graft-versus-host disease. Blood 2013;121:3274-3283.
36. Yanaba K, et al. CD19 expression in B cells regulates atopic dermatitis in a mouse model. Am J Pathol 2013;182:2214-2222.
37. Kuchroo VK, Martin CA, Greer JM, Ju ST, Sobel RA, Dorf ME. Cytokines and adhesion molecules contribute to the ability of myelin proteolipid protein-specific T cell clones to mediate experimental allergic encephalomyelitis. J Immunol 1993;151:4371-4382.
38. Park H, et al. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat Immunol 2005;6:1133-1141.
39. Linington C, Bradl M, Lassmann H, Brunner C, Vass K. Augmentation of demyelination in rat acute allergic encephalomyelitis by circulating mouse monoclonal antibodies directed against a myelin/oligodendrocyte glycoprotein. Am J Pathol 1988;130:443-454.
40. Lyons JA, San M, Happ MP, Cross AH. B cells are critical to induction of experimental allergic encephalomyelitis by protein but not by a short encephalitogenic peptide. Eur J Immunol 1999;29:3432-3439.
41. Matsushita T, Yanaba K, Bouaziz J-D, Fujimoto M, Tedder TF. Regulatory B cells inhibit EAE initiation in mice while other B cells promote disease progression. J Clin Invest 2008;118:3420-3430.
42. Hahn BH, Singh RR. Animal models of systemic lupus erythematosus. In: Wallace DJ, Hahn BH eds. Dubois' Lupus Erythematosus. Philadelphia, PA: Lippincott Williams and Wilkins, 2007:299-355.
43. 1 mice. J Immunol 2010;184:4789-4800.
44. Watanabe R, et al. Regulatory B cells (B10 cells) have a suppressive role in murine lupus: CD19 and B10 cell deficiency exacerbates systemic autoimmunity. J Immunol 2010;184:4801-4809.
45. lpr mice. J Immunol 2012;188:678-685.
46. Hobeika E, et al. Testing gene function early in the B cell lineage in mb1-cre mice. Proc Natl Acad Sci USA 2006;103:13789-13794.
47. Kuhn R, Lohler J, Rennick D, Rajewsky K, Muller W. Interleukin-10-deficient mice develop chronic enterocolitis. Cell 1993;75:263-274.
48. Mizoguchi A, Mizoguchi E, Smith RN, Preffer FI, Bhan AK. Suppressive role of B cells in chronic colitis of T cell receptor α mutant mice. J Exp Med 1997;186:1749-1756.
49. Yanaba K, Yoshizaki A, Asano Y, Kadono T, Tedder TF, Sato S. IL-10-producing regulatory B10 cells inhibit intestinal injury in a mouse model. Am J Pathol 2011;178:735-743.
50. Asseman C, Mauze S, Leach MW, Coffman RL, Powrie F. An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation. J Exp Med 1999;190:995-1004.
51. Trentham DE, Townes AS, Kang AH. Autoimmunity to type II collagen an experimental model of arthritis. J Exp Med 1977;146:857-868.
52. Yanaba K, Hamaguchi Y, Venturi GM, Steeber DA, St. Clair EW, Tedder TF. B cell depletion delays collagen-induced arthritis in mice: arthritis induction requires synergy between humoral and cell-mediated immunity. J Immunol 2007;179:1369-1380.
53. Mauri C, Gray D, Mushtaq N, Londei M. Prevention of arthritis by interleukin 10-producing B cells. J Exp Med 2003;197:489-501.
54. Evans JG, et al. Novel suppressive function of transitional 2 B cells in experimental arthritis. J Immunol 2007;178:7868-7878.
55. Yang M, et al. IL-10-producing regulatory B10 cells ameliorate collagen-induced arthritis via suppressing Th17 cell generation. Am J Pathol 2012;180:2375-2385.
56. Neves P, et al. Signaling via the MyD88 adaptor protein in B cells suppresses protective immunity during Salmonella typhimurium infection. Immunity 2010;33:777-790.
57. Horikawa M, Minard-Colin V, Matsushita T, Tedder TF. Regulatory B cell production of IL-10 inhibits lymphoma depletion during CD20 immunotherapy in mice. J Clin Invest 2011;121:4268-4280.
58. Bichi R, et al. Human chronic lymphocytic leukemia modeled in mouse by targeted TCL1 expression. Proc Natl Acad Sci USA 2002;99:6955-6960.
59. Iwata Y, et al. Characterization of a rare IL-10-competent B cell subset in humans that parallels mouse regulatory B10 cells. Blood 2011;117:530-541.
60. Duddy M, et al. Distinct effector cytokine profiles of memory and naive human B cell subsets and implication in multiple sclerosis. J Immunol 2007;178:6092-6099.
61. + T-cell activation in vitro. Eur J Immunol 2010;40:2686-2691.
62. hi B cells exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic lupus erythematosus patients. Immunity 2010;32:129-140.
63. H17 differentiation. Sci Transl Med 2013;5:173ra123.